Dr. Toby Cosgrove, Cleveland Clinic CEO, provides insight to the Supreme Court's ruling on Obamacare subsidies and its impact on patients, hospitals and health insurers.
Shares of Humana jumped on Thursday after a report surfaced that the takeover bid by Aetna was moving forward.
An estimated 5 percent of the population is responsible for about half—or $1.4 trillion—of all U.S. health spending.
The CBO says a repeal of Obamacare would increase the US deficit by $353 billion over the next 10 years.
More than 240 people were charged with $712 million in false Medicare billing, the biggest health-care fraud takedown ever.
Two divergent U.S. core inflation readings could be related to the price of medical care. CNBC explores.
A damning 2009 New Yorker article was followed by "unprecedented" savings on Medicare costs in a Texas town.
The U.S. Supreme Court on Monday declined to hear a new challenge to the Obamacare law that took aim at the so-called death panel.
CNBC's John Harwood reports the House has passed a $200 billion Medicare overhaul bill. The bill will now go to the Senate, where it is expected to pass.
A bipartisan compromise to overhaul Medicare bucks the popular impression that Washington can't accomplish anything at all.
Jason Furman, CEA chairman, provides reaction to the House's fiscal plan for the 2016 budget. The GOP budget would cut jobs, says Furman.
Rep. Tom Price, (R-Ga.), discusses his proposal to reduce government spending by $5.5 trillion and includes repealing Obamacare.
Your retirement may be at risk, and the rising costs of Social Security, public pensions and health care are the primary reasons why.
A leading group of physicians is warning that high prices of specialty drugs is creating barriers to care for patients.
The $1.08 trillion budget sought by federal health officials includes a request they be able to negotiate some drug prices for Medicare.
The White House has proposed an alternative Medicare model. The proposal would phase out fee-for-service, reports CNBC's John Harwood.
The Obama administration said more Medicare payments will be linked to the value given patients, as opposed to a fee for services.
The head of Medicare reversed two decisions to halt payments to health providers after being contacted by elected officials, The Wall Street Journal reported.
Drug giant Sanofi is juggling legal and regulatory issues surrounding three cases involving alleged payments or inducements to medical providers.
A lawsuit accuses drug maker Sanofi and top executives, including its ousted CEO, of a million-dollar kickback scheme to promote diabetes drug sales.